Wladimir Hogenhuis compensation by year
Ultragenyx Pharmaceutical Summary Compensation Table · the one fiscal year held| Component | FY2018 |
|---|---|
| Salary | $110,923 |
| Bonus | $200,000 |
| Stock awards | $1,159,500 |
| Option awards | $3,504,533 |
| Non-equity incentive | $67,021 |
| Pension and deferred compensation | $0 |
| All other | $215,827 |
| Total | $5,257,804 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ultragenyx Pharmaceutical Inc. DEF 14A filed April 22, 2019, accession 0001193125-19-112719, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Ultragenyx Pharmaceutical Inc. filed document, accession 0001193125-19-112719. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2019.
Equity holdings
unvested awards at FY2018 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 15,000 | $652,200 | — |
| Option | 75,000 | — | $77.30 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Ultragenyx Pharmaceutical Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.
Ultragenyx Pharmaceutical’s named executive officers, FY2018
as the company reported each| Named executive officer | Role | FY2018 total |
|---|---|---|
| Wladimir Hogenhuis · this page | Chief Operating Officer and Executive Vice President | $5,257,804 |
| Camille Bedrosian | Chief Medical Officer and Executive Vice President | $4,846,292 |
| Emil Kakkis | President and Chief Executive Officer | $4,845,627 |
| Shalini Sharp | Chief Financial Officer and Executive Vice President | $2,081,721 |
| Karah Parschauer | General Counsel and Executive Vice President | $2,036,330 |
| Thomas Kassberg | Chief Business Officer and Executive Vice President | $1,692,660 |
| John Pinion | Chief Quality Officer and Executive Vice President, Translational Sciences | $1,564,878 |
| Erik Harris | Chief Commercial Officer and Executive Vice President | $641,070 |
The full Ultragenyx Pharmaceutical compensation record
free company briefThis page is one person within Ultragenyx Pharmaceutical's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Ultragenyx Pharmaceutical proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Ultragenyx Pharmaceutical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.